• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素I转换酶抑制剂(SQ 14,225)的血压与血药浓度之间的关系。

Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).

作者信息

Honda M, Izumi Y, Kawahara Y, Hatano M

出版信息

Jpn Circ J. 1981 Sep;45(9):1025-9. doi: 10.1253/jcj.45.1025.

DOI:10.1253/jcj.45.1025
PMID:7029028
Abstract

The time courses of mean blood pressure (MBP), plasma renin activity (PRA), plasma aldosterone (PA), serum prostaglandin E (PGE), serum angiotensin I converting enzyme (ACE), and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225) (captopril) were studied in 6 patients with essential hypertension (5 men and 1 woman, aged 44 +/- 5.6 (mean +/- S.E.) years) before and 30, 60, 120 and 180 min after administration of 25 mg captopril. MBP and ACE began to fall within 30 min and reached a significant minimum between 60 and 180 min after captopril administration. PRA was significantly increased 60 min after captopril administration and continued for 180 min. On the other hand, PA had begun to fall significantly 180 min after captopril administration. The blood levels of captopril were significantly increased 30 min after captopril administration, with a peak at 120 min. The levels at 180 min were half the peak. The levels of PGE were not significantly changed within 180 min after captopril administration. These results suggest a discrepancy between the changes in MBP and the blood levels of captopril. The blood pressure lowering effect may be due to inhibition of angiotensin II (Ang. II) during the short-acting effect, and due to decrease of PA, metabolites of captopril, increase of kinin in the blood, inhibition of the slow pressor effect of Ang. II, increases of other depressor hormones such as prostacyclin and other depressor mechanisms during the long-acting effect.

摘要

对6例原发性高血压患者(5例男性,1例女性,年龄44±5.6(均值±标准误)岁)在服用25毫克卡托普利之前以及之后30、60、120和180分钟,研究了平均血压(MBP)、血浆肾素活性(PRA)、血浆醛固酮(PA)、血清前列腺素E(PGE)、血清血管紧张素I转换酶(ACE)以及血管紧张素I转换酶抑制剂(SQ 14,225)(卡托普利)的血药浓度的时间进程。服用卡托普利后30分钟内MBP和ACE开始下降,在60至180分钟之间降至显著最低值。服用卡托普利60分钟后PRA显著升高,并持续180分钟。另一方面,服用卡托普利180分钟后PA已开始显著下降。服用卡托普利30分钟后卡托普利的血药浓度显著升高,在120分钟时达到峰值。180分钟时的浓度为峰值的一半。服用卡托普利180分钟内PGE的水平无显著变化。这些结果提示MBP变化与卡托普利血药浓度之间存在差异。降压作用可能在短效作用期间归因于对血管紧张素II(Ang. II)的抑制,而在长效作用期间归因于PA的降低、卡托普利代谢产物的增加、血液中激肽的增加、对Ang. II缓慢升压作用的抑制、其他降压激素如前列环素的增加以及其他降压机制。

相似文献

1
Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).血管紧张素I转换酶抑制剂(SQ 14,225)的血压与血药浓度之间的关系。
Jpn Circ J. 1981 Sep;45(9):1025-9. doi: 10.1253/jcj.45.1025.
2
Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.血管紧张素I转换酶抑制剂(SQ 14,225)对高血压患者血压及类固醇激素对血管紧张素II和促肾上腺皮质激素输注反应的影响。
Jpn Circ J. 1982 Mar;46(3):267-73. doi: 10.1253/jcj.46.267.
3
Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225).食物对血管紧张素I转换酶抑制剂(SQ 14,225)临床疗效的影响。
Tohoku J Exp Med. 1983 Mar;139(3):279-86. doi: 10.1620/tjem.139.279.
4
Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in nomal men.
Endocrinol Jpn. 1979 Jun;26(3):411-8. doi: 10.1507/endocrj1954.26.411.
5
[Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].卡托普利抑制转化酶对原发性高血压患者动脉血压、肾素及醛固酮的影响
Arch Inst Cardiol Mex. 1982 Jul-Aug;52(4):295-300.
6
A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.单次口服卡托普利对血压、血浆肾素活性及血清血管紧张素转换酶水平的影响之间的差异。
Int J Clin Pharmacol Ther Toxicol. 1983 Nov;21(11):569-74.
7
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.卡托普利治疗临床高血压。肾素 - 血管紧张素系统各组分及身体成分的变化与血压下降的关系,并附关于转换酶抑制期间血管紧张素II测量的说明
Br Heart J. 1980 Sep;44(3):290-6. doi: 10.1136/hrt.44.3.290.
8
Effects of various doses of captopril on plasma aldosterone concentrations in patients with essential hypertension.
Endocrinol Jpn. 1982 Dec;29(6):717-23. doi: 10.1507/endocrj1954.29.717.
9
Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.卡托普利与马来酸依那普利:降压及激素效应比较
J Cardiovasc Pharmacol. 1985;7 Suppl 1:S12-5.
10
[Renin and aldosterone secretion under converting enzyme inhibition].[转化酶抑制下的肾素和醛固酮分泌]
Nihon Naibunpi Gakkai Zasshi. 1983 Aug 20;59(8):1099-116. doi: 10.1507/endocrine1927.59.8_1099.